Cite
HARVARD Citation
Nagashima, S. et al. (2020). Long‐term efficacy of the sodium–glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome. Journal of diabetes investigation. 11 (5), pp. 1363-1365. [Online].